Avidity Partners Management LP 13D and 13G filings for Oruka Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-14 7:38 pm Purchase | 2024-09-30 | 13G | Oruka Therapeutics Inc. ORKA | Avidity Partners Management LP | 790,926 2.300% | 790,926 (New Position) | Filing |